P-463 Anti-Müllerian hormone levels in breast cancer patients receiving chemotherapy with or without concurrent luteinizing hormone-releasing hormone agonist: results from the PROMISE phase III trial
Marrocco, C, Conte, B, Rossi, G, Pirrone, C, Favero, D, Massarotti, C, Anserini, P, Fregatti, P, Cardinali, B, Buzzati, G, Levaggi, A, Poggio, F, Blondeaux, E, Del Mastro, L, Lambertini, M
Published in Human reproduction (Oxford) (29.06.2022)
Published in Human reproduction (Oxford) (29.06.2022)
Get full text
Journal Article